Division of Obstetrics

The Department of Obstetrics of the West China Second University Hospital of Sichuan University was approved as one of the first national key clinical specialty construction projects in 2010. We are currently the treatment and referral center for critically ill mothers in western China, the head unit of the Sichuan and Chengdu emergency obstetrics expert group, and the Sichuan Obstetrics and Gynecology Quality Control Center, undertaking the monitoring, prevention and treatment of perinatal critical illnesses, with a high level of obstetrical diagnosis and treatment of difficult and serious illnesses, making outstanding contributions to the reduction of maternal mortality in the region and the country.

We were the first in China to establish a laboratory of perinatal medicine in 1978, and we were the first in China to set up a working group on perinatal medicine and to publish for the first time in China the monograph "Basic and Clinical Perinatal Medicine", which became one of the birthplaces of academic obstetrics in China. In the 1980s, as the head of the national collaborative group, we conducted a study on postpartum hemorrhage and operative vaginal birth, which led to the revision of national standards for postpartum hemorrhage and the standardization of operative vaginal birth techniques. The level of our obstetrics consultation and treatment has long been a leader in China, with the ability to treat difficult and serious illnesses, as well as being a leader for setting clinical standards. We has conducted a series of in-depth clinical studies on the prevention and treatment of postpartum hemorrhage, and the related results have been published in the world's top academic journals for many times and adopted as evidence-based medicine level I evidence in the Guidelines for the Prevention and Treatment of Postpartum Hemorrhage. We have also made a major breakthrough in translational medicine research on severe pre-eclampsia, from basic research to obtaining granted patents, leading to clinical trials and finally developing a urinary complement factor kit for predicting pre-eclampsia. The research process has been supported by several national and provincial key projects, reflecting the leading level of industry-academia-research integration in China.

In addition, we have established a fetal medicine platform system to provide fetal medicine treatment services, such as fetal growth restriction, complicated twin pregnancies, fetal cardiac arrhythmia and fetal surgery.

We have authored and published 8 guidelines such as China's Guidelines for the Prevention and treatment of Postpartum Hemorrhage (2009) and (2014) and Guidelines for Normal Childbirth, and participated in writing other obstetric guidelines, consensus and clinical norms for more than 50 items. Our research achievements have won many honors, including the first prizes of science and technology at the provincial and ministerial levels and the first prize of the National Science and Technology Award for Maternal and Child Health.

Key Clinical Specialties of Gynaecology

As one of the first batch of national key clinical specialty construction programs, our department has been committed to promoting and innovation of new technologies to deliver innovative, multidisciplinary care for a full range of gynecologic conditions. To this point, we focus on developing our key gynecological specialties by constructing gynecological minimal invasive treatment platform, training talented specialists, etc. These efforts significantly increase the number of patients who benefit from minimal invasive surgery, including the malignant ones. Moreover, we pioneer in a number of domestic advanced technologies, such as single hole abdominal endoscopic surgery, robotic surgery, gasless suspension laparoscopy, total pelvic dissection of recurrent pelvic malignant tumors, and conversion of urine and feces, extensive hysterectomy preserving pelvic nerve function, etc. For women suffered from pelvic problems, our female pelvic medicine & reconstructive surgery program can provide individualized urogynecologic treatment plans, incorporating the most advanced surgical and nonsurgical options available. Guided by the needs of patients, we aim to deliver the best health care, to advance it through innovative research and education, and to improve the health and well-being of the patients.

Division of Neonatololgy

The Division of Neonatololgy of West China Second University Hospital was founded in 1973. It is one of the earliest neonatal medical units in China and the only unit accepted as National Key National Clinical Key Discipline (Neonatology) and National Neonatal Health Care Specialty in Yunnan, Guizhou, Sichuan and Tibet. The overall level of our discipline is at leading position in the country. It boasts for its "National Fund for Distinguished Young Scholars" and the only "Changjiang Scholars' innovation team of the Ministry of education" in Chinese pediatric community. The division is one of the first standardized training bases for neonatal perinatal medicine specialist physicians in China and neonatal specialist nurses in Sichuan Province. It is the only unit with Key Clinical Specialty Program of the National Health Commission in western region, and is the treatment and referral center for critically ill newborns in Sichuan Province and West China.

The Division of Neonatology has set up two wards at Huaxi and Jinjiang Campuses respectively. It includes a neonatal intensive care unit (NICU), a general neonatal ward and a neonatal surgery ward, with 305 beds, including 200 in NICU and 12 in surgery. More than 6,000 patients were admitted in 2021, in which more than 95% patients were critically ill, and more than 70% patients were difficulty and critically ill babies transferred in utero or after birth referred by medical units of all levels. The success rate of rescue reaches 99.7%.

There are 6 doctoral tutors and 15 master tutors in our team. Nearly 30 doctoral students and more than 50 master students have graduated in the past five years. The academic leader of the team, Professor MU Dezhi is the first neonatal physician who has been granted the National Funds for Distinguished Young Scientists in Medicine in China, young and middle-aged experts with outstanding contributions to national health and family planning, leader of Changjiang Scholars Innovation Team of the Ministry of Education, winner of the first National Famous Doctor and Outstanding Model Award. He is also the vice chairman of pediatrics branch and perinatal medicine branch of Chinese Medical Association, vice chairman of pediatric branch and neonatal branch of Chinese Medical Doctor Association. In our team, there are 51 physicians, 3 retired professors, 8 neonatal respiratory therapists, and 227 nurses. Among them, 13 have senior professional titles, 5 associate senior professional titles. Most of the physicians have doctoral degrees and overseas study or visit experiences. Many of them hold academic positions in international, national and provincial academic organizations.

We have a first-class scientific research platform in China, consisting of the "Pediatric Neurodevelopmental Laboratory, the Laboratory of Lung Development and Diseases, and the Laboratory of Perinatal Medicine. From 2017 to 2021, we were granted 22 national scientific research projects, 22 provincial and ministerial projects, and 48 patents, and published 500+ articles, including more than 140 in SCI journals, and won more than 10 national and provincial awards as well.